X
Change at the top at Adaptimmune as Noble stands down
https://pharmaphorum.com/news/change-at-the-top-at-adaptimmune-as-noble-stands-down/
Adaptimmune
Adaptimmune and GSK’s novel T-cell therapy works in solid tumours
Adaptimmune has more good news from its SPEAR T-cell therapy, yesterday unveiling encouraging early results in four patients with myxoid/round cell liposarcoma (MRCLS).
Adaptimmune revives ovarian cancer trial
T-cell trial will include controversial chemo agent fludarabine.
Adaptimmune progresses T-cell therapy trial
Biotech says “robust” clinical response in early stage trial.
FDA calls for hold on Adaptimmune T-cell trial
Regulator asks for information on trial design.